Myocardial Infarction, Acute
49
12
14
18
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
6.1%
3 terminated out of 49 trials
85.7%
-0.8% vs benchmark
12%
6 trials in Phase 3/4
6%
1 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 18 completed trials
Clinical Trials (49)
Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)
Timing of FFR-guided PCI for Non-IRA in STEMI and MVD (OPTION-STEMI)
Registry of Acute Myocardial Infarction
COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction
PERIODONTAL HEALTH IN PATIENTS ACUTELY ADMITTED FOR MYOCARDIAL INFARCTION: A CASE CONTROL STUDY
Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction
Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.
Korea Acute Myocardial Infarction Registry
WAMIF: Prospective Study in Young Women Presenting Acute Myocardial Infarction: Cohort Follow up
Asan Medical Center Myocardial Infarction Registry
Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion
Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy
TADCLOT- a Double Blind Randomized Controlled Trial
High-Sensitivity Troponin I in Addition to Guideline-Based Care in EMS
Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction
Benefit of Hypothermia in OHCA Complicating AMI
UNdeRstAnding Novel Variants in AcutE MyocardiaL Infarction in Young Adults
MSCs for Prevention of MI-induced HF
Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF